ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Urethral disorder | 20.07.01.002 | - | - | Not Available |
Urinary incontinence | 20.02.02.010; 17.05.01.008 | 0.000533% | | |
Urinary retention | 20.02.02.011 | 0.000533% | | |
Urinary tract disorder | 20.08.01.001 | - | - | Not Available |
Urinary tract infection | 20.08.02.001; 11.01.14.004 | 0.001598% | | |
Urticaria | 23.04.02.001; 10.01.06.001 | - | - | |
Uveitis | 10.02.01.023; 06.04.03.003 | 0.001332% | | |
Vaginal haemorrhage | 24.07.03.005; 21.08.01.001 | - | - | |
Vasculitis | 24.05.02.001; 10.02.02.006 | 0.000533% | | |
Vertigo | 17.02.12.002; 04.04.01.003 | - | - | |
Viral infection | 11.05.04.001 | 0.001066% | | Not Available |
Vision blurred | 06.02.06.007; 17.17.01.010 | 0.001865% | | |
Visual impairment | 06.02.06.008 | 0.003197% | | Not Available |
Vitreous haemorrhage | 24.07.05.005; 06.10.03.001 | - | - | |
Vomiting | 07.01.07.003 | 0.008792% | | |
Weight decreased | 13.15.01.005 | - | - | |
Weight increased | 13.15.01.006 | - | - | |
Tubulointerstitial nephritis | 20.05.02.002 | - | - | Not Available |
Mobility decreased | 17.02.05.018; 15.03.01.003; 08.01.03.030 | 0.000799% | | Not Available |
Peripheral swelling | 08.01.03.053; 02.05.04.015 | 0.001332% | | Not Available |
Abasia | 17.02.05.035; 08.01.02.007 | 0.000533% | | Not Available |
Tumour haemorrhage | 24.07.01.028; 16.32.03.008 | 0.000799% | | |
Ejection fraction decreased | 13.14.02.003 | 0.001598% | | |
Madarosis | 23.02.02.004; 06.06.04.010 | 0.000533% | | Not Available |
Malignant neoplasm progression | 16.16.01.005 | 0.002780% | | Not Available |
Metastases to peritoneum | 16.22.02.008; 07.21.03.003 | 0.000139% | | Not Available |
Musculoskeletal discomfort | 15.03.04.001 | - | - | Not Available |
Nodule | 08.03.05.002 | 0.000799% | | Not Available |
Transaminases increased | 13.03.01.015 | 0.000799% | | Not Available |
Haemorrhage | 24.07.01.002 | - | - | Not Available |